日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial

静脉注射伊马替尼治疗 COVID-19 ARDS 的疗效和安全性：一项随机、双盲、安慰剂对照临床试验

期刊:Critical Care
影响因子:9.3
doi:10.1186/s13054-023-04516-4
Atmowihardjo, Leila N; Schippers, Job R; Duijvelaar, Erik; Bartelink, Imke H; Bet, Pierre M; Swart, Noortje E L; van Rein, Nienke; Purdy, Keith; Cavalla, David; McElroy, Andrew; Fritchley, Sarah; Vonk Noordegraaf, Anton; Endeman, Henrik; van Velzen, Patricia; Koopmans, Matty; Bogaard, Harm Jan; Heunks, Leo; Juffermans, Nicole; Schultz, Marcus J; Tuinman, Pieter R; Bos, Lieuwe D J; Aman, Jurjan
发表日期：2023
文献求助 收藏

Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19

伊马替尼的药代动力学和药效学研究，旨在优化其从癌症治疗到新冠肺炎治疗的药物再利用。

期刊:European Journal of Pharmaceutical Sciences
影响因子:4.7
doi:10.1016/j.ejps.2023.106418
Baalbaki, Nadia; Duijvelaar, Erik; Said, Medhat M; Schippers, Job; Bet, Pierre M; Twisk, Jos; Fritchley, Sarah; Longo, Cristina; Mahmoud, Kazien; Maitland-van der Zee, Anke H; Bogaard, Harm Jan; Swart, Eleonora L; Aman, Jurjan; Bartelink, Imke H
肺炎
新冠
肿瘤
肿瘤免疫
微生物学
发表日期：2023
文献求助 收藏

Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis.

单核细胞趋化蛋白-1的多聚化不是糖胺聚糖依赖性跨内皮趋化作用所必需的

期刊:Biochemical Journal
影响因子:4.3
doi:10.1042/0264-6021:3580737
Ali S, Palmer A C, Fritchley S J, Maley Y, Kirby J A
细胞生物学
发表日期：2001
文献求助 收藏

The antagonism of interferon-gamma (IFN-gamma) by heparin: examination of the blockade of class II MHC antigen and heat shock protein-70 expression

肝素对干扰素-γ (IFN-γ) 的拮抗作用：对 II 类 MHC 抗原和热休克蛋白-70 表达阻断的检测

期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1046/j.1365-2249.2000.01178.x
Fritchley, S J; Kirby, J A; Ali, S
IFN-γ
发表日期：2000
文献求助 收藏